ArticleEndocrine journal2026

Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients.

Haruhiko Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.